Evaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithms

Jacob K Kariuki1, Eileen M Stuart-Shor, Suzanne G Leveille

  • 1College of Nursing and Health Sciences, University of Massachusetts, Boston, USA. Jacob.Kariuki@umb.edu.

Insights

Non-laboratory cardiovascular disease (CVD) risk assessment tools like Gaziano and Framingham are crucial for resource-limited settings. Further external validation is needed to confirm their effectiveness across diverse populations.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Cardiovascular disease (CVD) poses a significant health burden, particularly in resource-constrained nations.
  • Effective primary and secondary prevention strategies are essential for managing CVD.
  • Absolute cardiovascular (CV) risk assessment guides preventive and treatment decisions.

Purpose of the Study:

  • To evaluate non-laboratory based CV risk assessment algorithms.
  • To assess algorithm performance against established benchmarks for clinical utility.

Main Methods:

  • A comprehensive literature search identified non-laboratory based risk prediction algorithms.
  • Algorithms were evaluated using Cooney and colleagues' benchmarks for clinically useful tools.

Main Results:

  • Five non-laboratory based CV risk assessment algorithms were identified.
  • Gaziano and Framingham algorithms met statistical and endpoint criteria.
  • Gaziano algorithm showed optimal discrimination upon external validation and user-friendly formats.

Conclusions:

  • Gaziano and Framingham algorithms largely meet clinical utility criteria.
  • External validation in diverse populations is recommended to confirm performance and applicability.
  • Enhanced clinician confidence requires robust validation of these risk assessment tools.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
880
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
2.1K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
428